2,6-dimethyloctane-1,8-dioic acid has been researched along with bms 187745 in 1 studies
| Studies (2,6-dimethyloctane-1,8-dioic acid) | Trials (2,6-dimethyloctane-1,8-dioic acid) | Recent Studies (post-2010) (2,6-dimethyloctane-1,8-dioic acid) | Studies (bms 187745) | Trials (bms 187745) | Recent Studies (post-2010) (bms 187745) |
|---|---|---|---|---|---|
| 5 | 1 | 0 | 8 | 2 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jemal, M; Ouyang, Z | 1 |
1 trial(s) available for 2,6-dimethyloctane-1,8-dioic acid and bms 187745
| Article | Year |
|---|---|
Gas chromatography-mass spectrometric method for quantitative determination in human urine of dicarboxylic (dioic) acids produced in the body as a consequence of cholesterol biosynthesis inhibition.
Topics: Acyclic Monoterpenes; Anticholesteremic Agents; Cholesterol; Dicarboxylic Acids; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Gas Chromatography-Mass Spectrometry; Humans; Reproducibility of Results; Sensitivity and Specificity; Sulfonic Acids | 1998 |